Stocks News

LAST PRICE
142.4500
TODAY'S CHANGE (%)
Trending Down-0.5900 (-0.4125%)

Bid / Lots
142.2100/ 7
Ask / Lots
142.4500/ 3
Open / Previous Close
142.2600 / 143.0400
Day Range
Low 141.6900
High 144.4300
52 Week Range
Low 59.2200
High 145.5100
Volume
103,036
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Nov 8, 2024
- Glaukos Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  7:00AM ET on Friday Nov 08, 2024 by Dow Jones
  Companies Mentioned: GKOS
  
  Glaukos Announces Participation in Upcoming Investor Conferences
  ALISO VIEJO, Calif.--(BUSINESS WIRE)--November 08, 2024--
  Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to participate in the following upcoming investor conferences:
Nov 5, 2024
- DJ Glaukos Is Maintained at Overweight by JP Morgan, from 11:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  11:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: GKOS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/GKOS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 11:00 ET (16:00 GMT)
- DJ Glaukos Is Maintained at Overweight by Wells Fargo, from 10:20AM ET on Tuesday Nov 05, 2024 by Dow Jones
  10:20AM ET on Tuesday Nov 05, 2024 by Dow Jones
  Companies Mentioned: GKOS
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/GKOS/analyst-ratings
  
  (END) Dow Jones Newswires
  
  November 05, 2024 10:20 ET (15:20 GMT)
Nov 4, 2024
- Glaukos Q3 Non-GAAP Loss Narrows, Sales Increase; 2024 Sales Guidance Raised, from 5:14PM ET on Monday Nov 04, 2024 by MT Newswires
  5:14PM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: GKOS
  05:14 PM EST, 11/04/2024 (MT Newswires) -- Glaukos (GKOS) reported a Q3 non-GAAP loss late Monday of $0.28 per diluted share, narrowing from a $0.50 loss per share a year earlier. Analysts polled by Capital IQ expected a $0.48 loss per share. Net sa...
- -- Earnings Flash (GKOS) GLAUKOS CORPORATION Posts Q3 Revenue $96.7M, from 4:15PM ET on Monday Nov 04, 2024 by MT Newswires
  4:15PM ET on Monday Nov 04, 2024 by MT Newswires
  Companies Mentioned: GKOS
  04:15 PM EST, 11/04/2024 (MT Newswires) -- ...

Today
- Top Midday Gainers, from 1 hour ago by MT Newswires
  1 hour ago by MT Newswires
  Companies Mentioned: HON, RGEN, AXSM
- Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: IBB, RGEN, XLV, AZN, AXSM
- Sector Update: Health Care, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: RGEN
- Repligen Q3 Adjusted Earnings, Revenue Rise; 2024 Guidance Updated, from 4 hours ago by MT Newswires
  4 hours ago by MT Newswires
  Companies Mentioned: RGEN
- -- GUIDANCE: (RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.50 - $1.58, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: RGEN
- -- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $154.9M, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: RGEN
- -- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 EPS $0.43, from 5 hours ago by MT Newswires
  5 hours ago by MT Newswires
  Companies Mentioned: RGEN
- Repligen Reports Third Quarter 2024 Financial Results, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: RGEN
- *DJ Repligen 3Q Loss/Shr 1c >RGEN, from 5 hours ago by Dow Jones
  5 hours ago by Dow Jones
  Companies Mentioned: RGEN
Yesterday
- Inspire Medical Systems Signs $75 Million Accelerated Share Repurchase Deal, from 7:04AM ET on Monday Nov 11, 2024 by MT Newswires
  7:04AM ET on Monday Nov 11, 2024 by MT Newswires
  Companies Mentioned: GS, INSP

Glaukos Corp
NYSE:GKOSUnited States

Search Criteria

Nov 8, 2024

Glaukos Announces Participation in Upcoming Investor Conferences, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones

Nov 5, 2024

DJ Glaukos Is Maintained at Overweight by JP Morgan, from 11:00AM ET on Tuesday Nov 05, 2024 by Dow Jones

DJ Glaukos Is Maintained at Overweight by Wells Fargo, from 10:20AM ET on Tuesday Nov 05, 2024 by Dow Jones

Nov 4, 2024

Glaukos Q3 Non-GAAP Loss Narrows, Sales Increase; 2024 Sales Guidance Raised, from 5:14PM ET on Monday Nov 04, 2024 by MT Newswires

-- Earnings Flash (GKOS) GLAUKOS CORPORATION Posts Q3 Revenue $96.7M, from 4:15PM ET on Monday Nov 04, 2024 by MT Newswires

Peers Headlines

Today

Top Midday Gainers, from 1 hour ago by MT Newswires

Sector Update: Health Care Stocks Mixed Premarket Tuesday, from 4 hours ago by MT Newswires

Sector Update: Health Care, from 4 hours ago by MT Newswires

Repligen Q3 Adjusted Earnings, Revenue Rise; 2024 Guidance Updated, from 4 hours ago by MT Newswires

-- GUIDANCE: (RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.50 - $1.58, from 5 hours ago by MT Newswires

-- Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $154.9M, from 5 hours ago by MT Newswires

-- Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q3 EPS $0.43, from 5 hours ago by MT Newswires

Repligen Reports Third Quarter 2024 Financial Results, from 5 hours ago by Dow Jones

*DJ Repligen 3Q Loss/Shr 1c >RGEN, from 5 hours ago by Dow Jones

Yesterday

Inspire Medical Systems Signs $75 Million Accelerated Share Repurchase Deal, from 7:04AM ET on Monday Nov 11, 2024 by MT Newswires